Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-846-3 | CAS number: 127-51-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 1997
- Qualifier:
- according to guideline
- Guideline:
- other: ICH Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals
- Version / remarks:
- 1996
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Ionone, methyl-
- EC Number:
- 215-635-0
- EC Name:
- Ionone, methyl-
- Cas Number:
- 1335-46-2
- Molecular formula:
- C14H22O
- IUPAC Name:
- (1E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)pent-1-en-3-one
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: American Type Culture Collection, Manassas, VA
- Suitability of cells: working cell stocks were not used beyond passage 20 to assure karyotypic stability
- Cell cycle length: 10-14 hours
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 from male Sprague-Dawley rats
- Test concentrations with justification for top dose:
- 12.5, 25, 50 µg/mL
Top dose based on toxicity test with the test item: cell viability at 75 µg/mL: 0% - Vehicle / solvent:
- - solvent used: ethanol
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
- Cell density at seeding: 5 x 10^5 cells/25 cm^2 flask
DURATION
- Exposure duration: 4h (S9 activated); 4 or 20h (non-activated)
- Fixation time (start of exposure up to fixation or harvest of cells): 2h
NUMBER OF REPLICATIONS: 2
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED:
To prepare slides, the fixed cells were centrifuged at approximately 800 rpm for 5 minutes, the supernatant was aspirated, and 1 mL fresh fixative was added. After additional centrifugation (at approximately 800 rpm for 5 minutes) the supernatant fluid was decanted and the cells resuspended to opalescence in fresh fixative. A sufficient amount of cell suspension was dropped onto the center of a glass slide and allowed to air dry. Slides were identified by the study number, date prepared and the treatment condition. The dried slides were stained with 5% Giemsa, air dried and permanently mounted.
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE: a minimum of 100 per duplicate flask (200 in total)
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of cells: Polyploid and endoreduplicated cells were evaluated from each treatment flask per 100 metaphase cells scored.
- Methods, such as kinetochore antibody binding, to characterize whether micronuclei contain whole or fragmented chromosomes (if applicable):
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Toxicity of the test item (cell growth inhibition relative to the solvent control) in CHO cells when treated for 4 hours in the absence of S9-activation was 68% at 50 µg/mL, the highest test concentration evaluated for chromosome aberrations. The mitotic index at the highest dose level evaluated for chromosome aberrations, 50 µg/mL, was not reduced relative to the solvent control. The dose levels selected for microscopic analysis were 12.5, 25, and 50 µg/mL. The percentage of cells with structural aberrations in the test article-treated groups was not significantly increased above that of the solvent control (p>0.05, Fisher's exact test). The percentage of cells with numerical aberrations in the test article-treated groups was significantly increased above that of the solvent control at dose level 25 µg/mL (p<0.05, Fisher's exact test). The Cochran-Armitage test was negative for a dose response (p>0.05). The statistically significant increase in the percentages of numerically aberrant cells at dose level 25 µg/mL (5.0%) was within the range of the percentage of numerically aberrant cells observed with the historical solvent control (0.0-6.5%). Therefore, the statistically significant increase in numerically aberrant cells in the non-activated 4 hour exposure group were considered not biologically significant. The percentage of structurally damaged cells in the MMC group was found to be statistically significant (26.0%).
Toxicity of the test item (cell growth inhibition relative to the solvent control) in CHO cells when treated for 4 hours in the presence of S9-activation was 61% at 50 µg/mL, the highest test concentration evaluated for chromosome aberrations. The mitotic index at the highest dose level evaluated for chromosome aberrations, 50 µg/mL, was not reduced relative to the solvent control. The dose levels selected for microscopic analysis were 12.5, 25, and 50 µg/mL. The percentage of cells with structural aberrations in the test article-treated groups was statistically increased above that of the solvent control at dose level 50 µg/mL (p<0.05, Fisher's exact test). The Cochran-Armitage test was also positive for a dose response (p<0.05). However, the statistically significant increase in the percentage of structurally aberrant cells at dose level 50 (µg/mL (3.5%) was within the range of the percentage of structurally aberrant cells observed with the historical solvent control (0.0-6.0%). Therefore, the statistically significant increases in structurally aberrant cells in the S9 activated 4 hour exposure group were considered not biologically significant. The percentage of cells with numerical aberrations in the test article-treated groups was not significantly increased above that of the solvent control (p>0.05, Fisher's exact test). The percentage of structurally damaged cells in the CP group was found to be statistically significant (20.5%).
In the absence of a positive response in the non-activated 4 hour exposure group, slides from the non-activated 20 hour exposure group were evaluated for chromosome aberrations. Toxicity of the test item (cell growth inhibition relative to the solvent control) was 66% at 50 µg/mL, the highest test concentration evaluated for chromosome aberrations in the non-activated 20 hour continuous exposure group. The mitotic index at the highest dose level evaluated for chromosome aberrations, 50 µg/mL, was 30% reduced relative to the solvent control. The dose levels selected for microscopic analysis were 12.5, 25, and 50 µg/mL. The percentage of cells with structural aberrations in the test article-treated groups was significantly increased above that of the solvent control at dose levels 12.5 and 25 µg/mL (p<0.05 and 0.01, respectively, Fisher's exact test). The Cochran-Armitage test was negative for a dose response (p>0.05). The percentage of cells with numerical aberrations in the test article-treated groups was not significantly increased above that of the solvent control (p>0.05, Fisher's exact test). The percentage of structurally damaged cells in the MMC group was found to be statistically significant (37.0%). See table 1 for all results.
Any other information on results incl. tables
Tabel 1: Cytogenetic analysis of CHO cells treated with the test item in the presence and absence of exogenous metabolic activation
Treatment |
S9 Activation |
Treatment1Time (Hours) |
Mitotic Index |
Cells Scored |
Aberrations Per Cell2(Mean ± SD) |
Cells With Aberrations3(%) |
|
Numerical |
Structural |
||||||
Ethanol |
- |
4 |
9.9 |
200 |
0.055 ± 0.229 |
1.5 |
5.5 |
Test item |
|
||||||
12.5 µg/mL |
- |
4 |
11.9 |
200 |
0.080 ± 0.323 |
4.5 |
6.5 |
25 µg/mL |
- |
4 |
12.4 |
200 |
0.220 ± 1.319 |
5.0* |
5.5 |
50 µg/mL |
- |
4 |
11.8 |
200 |
0.150 ± 0.800 |
3.0 |
8.0 |
MMC, 0.2 µg/mL |
- |
4 |
11.6 |
200 |
0.375 ± 0.943 |
2.5 |
26.0** |
Ethanol |
+ |
4 |
12.1 |
200 |
0.005 ± 0.071 |
1.5 |
0.5 |
Test item |
|
||||||
12.5 µg/mL |
+ |
4 |
10.5 |
200 |
0.000 ± 0.000 |
1.5 |
0.0 |
25 µg/mL |
+ |
4 |
10.2 |
200 |
0.030 ± 0.171 |
4.0 |
3.0 |
50 µg/mL |
+ |
4 |
12.8 |
200 |
0.035 ± 0.184 |
4.5 |
3.5* |
CP, 10 µg/mL |
+ |
4 |
6.4 |
200 |
0.440 ± 1.359 |
2.5 |
20.5** |
Ethanol |
- |
20 |
8.4 |
200 |
0.055 ± 0.269 |
5.0 |
4.5 |
Test item |
|
||||||
12.5 µg/mL |
- |
20 |
10.0 |
200 |
0.155 ± 0.777 |
7.5 |
10.0* |
25 µg/mL |
- |
20 |
9.5 |
200 |
0.335 ± 1.233 |
3.0 |
14.5** |
50 µg/mL |
- |
20 |
5.9 |
200 |
0.175 ± 1.025 |
7.5 |
8.5 |
MMC, 0.1 µg/mL |
20 |
8.9 |
100 |
0.720 ± 1.577 |
4.5 |
37.0** |
1Cells from all treatment conditions were harvested at 20 hours after the initiation of the treatments.
2Severely damaged cells were counted as 10 aberrations.
3*, p ≤ 0.05; **, p ≤ 0.01; Fisher's exact test.
Applicant's summary and conclusion
- Conclusions:
- The test item was concluded to be negative in both the absence and presence of S9 activation for the induction of numerical chromosome aberrations in Chinese hamster ovary (CHO) cells.
- Executive summary:
The test item was tested in the chromosome aberration assay using Chinese hamster ovary (CHO) cells in both the absence and presence of an Aroclor-induced S9-activation system according to OECD 473. A preliminary toxicity test was performed to establish the dose range for the chromosome aberration assay. The chromosome aberration assay was used to evaluate the clastogenic potential of the test article. Ethanol was determined to be the solvent of choice based on the solubility of the test article and compatibility with the target cells. The test article was soluble in ethanol at a concentration of 500 mg/mL, the maximum concentration tested. In the preliminary toxicity assay, the maximum dose tested was 2060 µg/mL. This dose level represents the 10mM concentration based on a test article molecular weight of 206.30. Visible precipitate was observed in treatment medium at dose levels > 206 µg/mL in the non-activated and S9 activated 4 hour exposure groups, and at dose levels > 618 µg/mL in the non-activated 20 hour exposure group. Dose levels < 61.8 µg/mL in the 4 hour exposure groups, and < 206 µg/mL in the non-activated 20 hour exposure group were soluble in treatment medium. Selection of dose levels for the chromosome aberration assay was based on cell growth inhibition relative to the solvent control. Substantial toxicity, i.e., at least ~50% cell growth inhibition, was observed at dose levels of 61.8 µg/mL in both the non-activated and S9-activated exposure groups. Based on these findings, the doses chosen for the chromosome aberration assay ranged from 12.5 to 175 µg/mL for both the non-activated and the S9-activated exposure groups. In the chromosome aberration assay, the cells were treated for 4 and 20 hours in the non-activated test system and for 4 hours in the S9-activated test system, and all cells were harvested at 20 hours after treatment initiation. The test article was soluble in treatment medium at all concentrations tested. Toxicity (cell growth inhibition) was 68% and 66% at the highest dose level evaluated for chromosome aberrations, 50 µg/mL, in the non-activated 4 hour and 20 hour exposure groups, respectively. Toxicity (cell growth inhibition) was approximately 61% at the highest dose level evaluated for chromosome aberrations, 50 µg/mL, in the S9 activated study. Initially, the non-activated and S9-activated 4 hour exposure groups were scored for structural and numerical chromosome aberrations. No statistically significant increases in structural chromosome aberrations were observed in the non-activated 4 hour exposure group relative to the solvent control group, regardless of dose level (p>0.05, Fisher's exact test). A statistically significant increase in structural chromosome aberrations was observed in the S9-activated 4 hour exposure group relative to the solvent control group, at dose level 50 µg/mL (p<0.05, Fisher's exact test). The Cochran-Armitage test was also positive for a dose response (p<0.05). However, the statistically significant increase in the percentage of structurally aberrant cells at dose level 50 µg/mL (3.5%) was within the range of the percentage of structurally aberrant cells observed with the historical solvent control (0.0-6.0%). Therefore, the statistically significant increase in structurally aberrant cells in the S9 activated 4 hour exposure group was considered not biologically significant. A statistically significant increase in numerical chromosome aberrations was observed in the non-activated 4 hour exposure group relative to the solvent control group, at dose level 25 µg/mL (p<0.05, Fisher's exact test). The Cochran-Armitage test was negative for a dose response (p>0.05). The statistically significant increase in the percentages of numerically aberrant cells at dose level 25 (µg/mL (5.0%) was within the range of the percentage of numerically aberrant cells observed with the historical solvent control (0.0-6.5%). Therefore, the statistically significant increase in numerically aberrant cells in the non-activated 4 hour exposure group was considered not biologically significant. No statistically significant increases in numerical chromosome aberrations were observed in the S9-activated 4 hour exposure group relative to the solvent control group, regardless of dose level (p>0.05, Fisher's exact test). In the absence of a positive response in the non-activated 4 hour exposure group, the non-activated 20 hour continuous exposure group was evaluated for structural and numerical chromosome aberrations. Statistically significant increases in structural chromosome aberrations were observed in the non-activated 20 hour continuous exposure group relative to the solvent control group, at dose levels 12.5 and 25 µg/mL (p<0.05 and 0.01, respectively, Fisher's exact test). The Cochran-Armitage test was negative for a dose response (p>0.05). No statistically significant increases in numerical chromosome aberrations were observed in the non-activated 20 hour continuous exposure group relative to the solvent control group, regardless of dose level (p>0.05, Fisher's exact test). Based on the findings of this study, Methyl ionone was concluded to be positive in the absence of S9 activation for the induction of structural chromosome aberrations, negative in the presence of S9 activation for the induction of structural chromosome aberrations in Chinese hamster ovary (CHO) cells. Methyl ionone was concluded to be negative in both the absence and presence of S9 activation for the induction of numerical chromosome aberrations in Chinese hamster ovary (CHO) cells.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.